LINDSAY SHORT: Open Payments
NPI 1508029828 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 44 payments from 15 companies in 2025. Trend: 2023 $1,527 · 2024 $1,459 · 2025 $1,024
Food & beverage: $1,024
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 15 | $285 |
| PFIZER INC. | 7 | $131 |
| Procept Biorobotics Corporation | 1 | $126 |
| Merck Sharp & Dohme LLC | 4 | $112 |
| ABBVIE INC. | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| TOLMAR, INC. | 2 | $41 |
| CIVCO Medical Instruments | 1 | $30 |
| COLOPLAST CORP | 1 | $23 |
Products named: GEMTESA, XTANDI, AQUABEAM ROBOTIC SYSTEM, KEYTRUDA, BOTOX, PLUVICTO, Nubeqa, JATENZO.
Industry payments across NY — which companies pay providers there.
